Application | Comment | Organism |
---|---|---|
medicine | patients with left ventricular dysfunction have an increased risk of adverse events leading to discontinuation on angiotensin-converting enzyme inhibitor/angiotensin receptor blocker combination therapy compared with angiotensin-converting enzyme inhibitor alone. This excess risk, coupled with a lack of consistent mortality benefit, suggests that angiotensin receptor blocker should not routinely be added to angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|